CD80 and neoplasm: One such mechanism is represented by tumor-induced overexpression of CD80 (B7-1) on the surface of MDSCs, to which the inhibitory CTLA-4 (CD152) molecule expressed on CD4+CD25+ T cells binds with high affinity.